ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,631.22
0.28%
US Tech 100
19,892.00
0.50%
다우존스 지수
40,211.72
0.53%
Bitcoin
64,828.42
-0.04%
Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Transkaryotic Therapies (MM) (TKTX)

  7. Transkaryotic Therapies (MM) (TKTX) 뉴스

TKTX

Transkaryotic Therapies (TKTX)

Transkaryotic Therapies (MM)
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:TKTX
일자시간출처헤드라인심볼기업
2004/10/2222:06PR Newswire (US)TKT Completes Acquisition of Minority Interest in TKT Europe-5S ABNASDAQ:TKTXTranskaryotic Therapies (MM)
2004/10/2121:16PR Newswire (US)TKT Prevails Over Kirin-Amgen in House of Lords Dynepo Litigation Amgen Patent Found InvalidNASDAQ:TKTXTranskaryotic Therapies (MM)
2004/10/1609:34PR Newswire (US)TKT to Appeal Dynepo Ruling to Federal CircuitNASDAQ:TKTXTranskaryotic Therapies (MM)
2004/09/2906:05PR Newswire (US)TKT's I2S for Hunter Syndrome Receives Office of Orphan Products GrantNASDAQ:TKTXTranskaryotic Therapies (MM)
2004/09/2223:05PR Newswire (US)TKT Announces Appointments in Business Development and Intellectual PropertyNASDAQ:TKTXTranskaryotic Therapies (MM)
2004/09/2104:03PR Newswire (US)TKT to Present Research on Intrathecal Delivery of I2S For Hunter Syndrome at ASHGNASDAQ:TKTXTranskaryotic Therapies (MM)
2004/09/2023:28PR Newswire (US)TKT to Present at UBS Global Life Sciences ConferenceNASDAQ:TKTXTranskaryotic Therapies (MM)
2004/09/1322:39PR Newswire (US)TKT Gains Early Access to Dynepo(TM) Oncology DataNASDAQ:TKTXTranskaryotic Therapies (MM)
2004/09/0301:03PR Newswire (US)TKT to Present at Thomas Weisel's Healthcare Tailwinds ConferenceNASDAQ:TKTXTranskaryotic Therapies (MM)
2004/09/0110:07PR Newswire (US)TKT to Defend Vigorously U.S. Patent Litigation Brought by SeronoNASDAQ:TKTXTranskaryotic Therapies (MM)
2004/08/0322:30PR Newswire (US)TKT Reports Second Quarter 2004 Financial ResultsNASDAQ:TKTXTranskaryotic Therapies (MM)
2004/08/0316:00PR Newswire (US)TKT Announces Manufacturing Agreement for DynepoNASDAQ:TKTXTranskaryotic Therapies (MM)
2004/07/2800:32PR Newswire (US)TKT to Report Second Quarter Financial Results on August 3, 2004NASDAQ:TKTXTranskaryotic Therapies (MM)
2004/07/2700:27PR Newswire (US)TKT Completes Enrollment in Clinical Trial for Gaucher DiseaseNASDAQ:TKTXTranskaryotic Therapies (MM)
2004/07/2400:44PR Newswire (US)TKT to Present at Two Upcoming ConferencesNASDAQ:TKTXTranskaryotic Therapies (MM)
2004/07/2306:30PR Newswire (US)TKT Receives 'Wells Notice' from SECNASDAQ:TKTXTranskaryotic Therapies (MM)
2004/07/1606:00PR Newswire (US)TKT Receives Fast Track Designation For Iduronate-2-Sulfatase for Hunter SyndromeNASDAQ:TKTXTranskaryotic Therapies (MM)
2004/06/0404:07PR Newswire (US)TKT to Present at Pacific Growth Equities Life Sciences Growth ConferenceNASDAQ:TKTXTranskaryotic Therapies (MM)
2004/06/0222:58PR Newswire (US)TKT Announces Appointment of Dr. Marcio VolochNASDAQ:TKTXTranskaryotic Therapies (MM)
2004/05/1323:49PR Newswire (US)TKT to Present at Banc of America's 2004 Health Care ConferenceNASDAQ:TKTXTranskaryotic Therapies (MM)
2004/05/1101:38PR Newswire (US)Massachusetts Court Dismisses TKT Derivative LawsuitNASDAQ:TKTXTranskaryotic Therapies (MM)
2004/05/0100:10PR Newswire (US)TKT to Present at Deutsche Bank Securities 29th Annual Healthcare ConferenceNASDAQ:TKTXTranskaryotic Therapies (MM)
2004/04/2908:07PR Newswire (US)TKT Announces $90 Million Public Offering of 1.25% Senior Convertible Notes Due 2011NASDAQ:TKTXTranskaryotic Therapies (MM)
2004/04/2806:00PR Newswire (US)TKT Announces Proposed Offering Of Senior Convertible Notes Due 2011NASDAQ:TKTXTranskaryotic Therapies (MM)
2004/04/2722:52PR Newswire (US)Wayne P. Yetter Named Chairman of TKT's Board of DirectorsNASDAQ:TKTXTranskaryotic Therapies (MM)
2004/04/2722:41PR Newswire (US)TKT Announces First Quarter 2004 ResultsNASDAQ:TKTXTranskaryotic Therapies (MM)
2004/04/2623:01PR Newswire (US)TKT Begins Clinical Trial for Gaucher DiseaseNASDAQ:TKTXTranskaryotic Therapies (MM)
2004/04/2204:56PR Newswire (US)TKT to Report First Quarter Financial Results on April 27, 2004NASDAQ:TKTXTranskaryotic Therapies (MM)
2004/03/3003:09PR Newswire (US)TKT recouvre ses droits sur Dynepo en EuropeNASDAQ:TKTXTranskaryotic Therapies (MM)
2004/03/2715:58PR Newswire (US)TKT bekommt Rechte an Dynepo für Europa zurückNASDAQ:TKTXTranskaryotic Therapies (MM)
 검색 관련기사 보기:NASDAQ:TKTX

최근 히스토리

NYSE
BAC
Bank of America
AMEX
SPY
SPDR S&P 500
NYSE
MCD
McDonalds
NYSE
XOM
Exxon Mobil
AMEX
XLV
Health Care Select Sector
USOTC
ADDYY
Adidas (QX)
USOTC
BASFY
BASF (QX)
FX
USDEUR
US Dollar vs Euro
CCOM
SILVER
SILVER
NYSE
AXP
American Express
CCOM
US30
US 30
NYSE
KO
Coca Cola
CCOM
US100
US Tech 100
NASDAQ
MSFT
Microsoft
COIN
SOLUSD
Solana
NASDAQ
GOOGL
Alphabet
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유